915149-96-1

Upstream product

• 545-06-2 trichloroacetonitrile 
• 14218-11-2 2,3,4,6-Tetra-O-benzoyl-α-D-mannopyranosyl bromide 
• 883878-96-4 3,4-di-O-benzyl-1,2-O-(α-methoxybenzylidene)-6-O-(triisopropylsilyl)-β-D-mannopyranose 
• 883878-61-3 1-O-[2-O-benzoyl-3,4-di-O-benzyl-6-O-(triisopropylsilyl)-α-D-mannopyranosyl] trichloroacetimidate 
• 915150-04-8 1,2-O-(α-methoxybenzylidene)-6-O-(triisopropylsilyl)-β-D-mannopyranose 
• 123-76-2 levulinic acid 
• 98467-54-0 1,2-O-(α-methoxybenzylidene)-β-D-mannopyranose 
• 65236-82-0 1,2-O-(α-methoxybenzylidene)-3,4,6-tri-O-benzoyl-β-D-mannopyranose 
• 915150-35-5 4-Oxo-pentanoic acid (2S,3S,4S,5R,6R)-4,5-bis-benzyloxy-2-pent-4-enyloxy-6-triisopropylsilanyloxymethyl-tetrahydro-pyran-3-yl ester 
• 915150-34-4 Benzoic acid (2S,3S,4S,5R,6R)-4,5-bis-benzyloxy-2-pent-4-enyloxy-6-triisopropylsilanyloxymethyl-tetrahydro-pyran-3-yl ester 
• 915150-05-9 allyl 3,4-di-O-benzyl-2-O-levulinoyl-6-O-(triisopropylsilyl)-α-D-mannopyranoside 

Relevant academic research and scientific papers

Synthesis of a core arabinomannan oligosaccharide of Mycobacterium tuberculosis

The synthesis of a core arabinomannan (AM) oligosaccharide from Mycobacterium tuberculosis has been achieved using a convergent [6 + 6] glycosylation strategy and a defined set of building blocks. Dodecasaccharide 1, containing the key AM structural featu